期刊文献+

硒制剂治疗格雷夫斯眼病作用机制研究进展 被引量:2

Research Progress in Mechanism of Selenium Preparation in Treatment of Graves’ Ophthalmopathy
下载PDF
导出
摘要 格雷夫斯眼病(GO)主要累及眼眶组织,与细胞免疫、体液免疫及氧化应激密切相关。硒是人体必需的微量元素,以硒蛋白形式在体内发挥特定的生物学效应,对人类免疫系统的调节起重要作用。缺硒可导致免疫功能失调,可能是GO的独立危险因素,GO与缺硒相关,补硒对GO的治疗效果较好。硒制剂治疗GO的主要作用机制是抗氧化应激、免疫调节、抑制炎症细胞因子生成、抑制促甲状腺激素受体抗体及甲状腺过氧化物酶自身抗体分泌、抑制人类白细胞抗原DR的表达。 Graves ophthalmopathy(GO) mainly affects the orbital tissue,which is closely related to cellular immunity,humoral immunity and oxidative stress.Selenium,as an essential trace element in human body,exerts a specific biological effect in the form of selenoprotein and plays an important role in regulating human immune system.Selenium deficiency can lead to immune dysfunction and it may be an independent risk factor for GO.GO is related to selenium deficiency,and selenium supplementation has a good therapeutic effect on GO.Main mechanisms of action of selenium preparation in the treatment of GO are anti- oxidative stress,immune regulation,inhibition on the production of inflammatory cytokines,inhibition on the secretion of TRAb and TPOAb and inhibition on the expression of HLA-DR in cells.
作者 韦艳鸿 庞翠军 WEI Yanhong;PANG Cuijun(Department of Endocrinology and Metabolism,Wuming Hospital of Guangxi Medical University ,Nanning 530199,China;Department of Endocrinology and Metabolism,the Second Affiliated Hospital of Guangxi Medical University,Nanning 530000,China)
出处 《医学综述》 2019年第16期3242-3247,共6页 Medical Recapitulate
关键词 格雷夫斯眼病 氧化应激 Graves ophthalmopathy Selenium Oxidative stress
  • 相关文献

参考文献7

二级参考文献47

  • 1秦贵军,罗方,赵艳艳,张素华,宋方州.IL-1β对体外人Graves眼病球后成纤维细胞分泌RANTES的影响[J].郑州大学学报(医学版),2005,40(3):485-488. 被引量:6
  • 2邹建文,李卫国.Graves’病患者血清IFN-γ、IL-2及IL-6的动态观察[J].放射免疫学杂志,2006,19(3):183-185. 被引量:6
  • 3孙玲玲,褚迅,黄薇,毕富勇.CD40基因多态性与Graves病的相关性研究[J].实用医学杂志,2007,23(5):655-657. 被引量:3
  • 4Naziroglu M, Cay M. Protective role of intraperitoneally administered vitamin E and selenium on the antioxidative defense mechanisms in rats with diabetes induced by streptozotocin. Biol Trace Elem Res, 2001, 79(2) : 149-159. 被引量:1
  • 5Beliaeva NF, Gorodetskii VK, Tochilkin AI, et al. Vanadium compounds-a new class of therapeutic agents for the treatment of diabetes mellitus. Vopr Med Khim, 2000, 46(4) : 344-360. 被引量:1
  • 6Anderson RA. Chromium in the prevention and control of diabetes. Diabetes Metab, 2000, 26( 1 ) : 22-27. 被引量:1
  • 7Opara E. Oxidative stress, micronutrients, diabetes mellitus and its complications. J R Soc Health, 2002, 122(1) : 28-34. 被引量:1
  • 8De Carli M. D' Elios MM, Zancuoghi G, et al. Human Th1 and Th2 cells: functional properties, regulation of development and roles in autoimmunity. Autoimmunity 1994, 18:301. 被引量:1
  • 9Shimada A, Charlton B, Rohane P,et al. Immune regulation in type 1 diabetes. Autoimmune, 1996, 9:263. 被引量:1
  • 10Rackietan N, Rackietan ML, Nadkarni MR. Studies on diabeto-genic action of streptozotocin (NSC-37917). Cancer Chemoth Reports, 1993,29:91-95. 被引量:1

共引文献51

同被引文献37

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部